Our objective is to present the pharmacological mechanisms, safety profiles, and regulatory status of prominent approved and unapproved peptides marketed direct to patients, including AOD-9604 (anti-obesity drug 9604), BPC-157 (body protection compound 157), CJC-1295, FS-344 (follistatin-344), GHK-Cu (glycyl-l-histidyl-l-lysine copper), ipamorelin, MOTS-C (mitochondrial ORF of the 12S rRNA type-c), sermorelin, SS-31 (elamipretide), tesamorelin (Egrifta), T4 (thymosin beta-4), and TB-500 (thymosin beta-4 fragment)
Benzie, I
doi: 10.1136/rmdopen-2022-002348 51 GrasesFCosta-BauzaARoigJRodriguezA
Most people notice the most when they come in consistently over several weeks and pair the drips with good skincare, solid sleep, and steady hydration
Brand Transparency Trustworthy companies provide clear ingredient sourcing, scientific references and manufacturing location details